Alliancebernstein L.P. United Therapeutics Corp Transaction History
Alliancebernstein L.P.
- $290 Billion
- Q2 2025
A detailed history of Alliancebernstein L.P. transactions in United Therapeutics Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 296,071 shares of UTHR stock, worth $89.2 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
296,071
Previous 454,983
34.93%
Holding current value
$89.2 Million
Previous $140 Million
39.34%
% of portfolio
0.03%
Previous 0.05%
Shares
32 transactions
Others Institutions Holding UTHR
# of Institutions
740Shares Held
44MCall Options Held
334KPut Options Held
314K-
Black Rock Inc. New York, NY5.47MShares$1.65 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.45MShares$1.34 Billion0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.37MShares$714 Million12.42% of portfolio
-
State Street Corp Boston, MA2.17MShares$653 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.12MShares$639 Million0.86% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $13.7B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...